Go Pro
Michael Yee

Michael Yee Analyst Performance

Global Head of Biotechnology Equity Research & Managing Director - Senior Biotechnology Analyst at UBS Group

Michael Yee is a stock analyst at UBS Group focused in the healthcare sector, covering 50 publicly traded companies. Over the past year, Michael Yee has issued 101 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Michael Yee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Yee's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
210 Last 12 Years
Buy Recommendations
83.90% 172 Buy Ratings
Companies Covered
50 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.0%2 ratings
Buy82.9%170 ratings
Hold15.6%32 ratings
Sell0.5%1 ratings

Out of 205 total stock ratings issued by Michael Yee at UBS Group, the majority (82.9%) have been Buy recommendations, followed by 15.6% Hold, 1.0% Strong Buy, and 0.5% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
86.0% of companies on NASDAQ
43 companies
NYSE
14.0% of companies on NYSE
7 companies

Michael Yee, an analyst at UBS Group, currently covers 50 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
49 companies
98.0%
Miscellaneous
1 company
2.0%

Michael Yee of UBS Group specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
39 companies
78.0%
PHARMACEUTICALS
9 companies
18.0%
Miscellaneous
1 company
2.0%
HEALTHCARE TECHNOLOGY
1 company
2.0%

Michael Yee's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
9/28/2026Reiterated Rating$55.72Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
9/28/2026Boost Price Target$528.06$615.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9/28/2026Boost Price Target$88.13$120.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/22/2026Reiterated Rating$269.08Buy
Moderna, Inc. stock logo
MRNA
Moderna
9/22/2026Reiterated Rating$183.42Neutral
Amgen Inc. stock logo
AMGN
Amgen
9/17/2026Reiterated Rating$378.36$430.00Buy
TRAX
First Tracks Biotherapeutics
9/16/2026Initiated Coverage$38.47Buy
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
9/10/2026Upgrade$31.91Strong-Buy
Moderna, Inc. stock logo
MRNA
Moderna
9/3/2026Set Price Target$150.81$81.00
Moderna, Inc. stock logo
MRNA
Moderna
9/3/2026Downgrade$150.81Sell
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/2/2026Initiated Coverage$279.78$320.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/28/2026Boost Price Target$221.15$265.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/20/2026Boost Price Target$151.73$175.00Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
8/14/2026Initiated Coverage$18.46$19.00Neutral
Schrodinger, Inc. stock logo
SDGR
Schrodinger
8/14/2026Initiated Coverage$18.46$19.00Neutral
TRAX
First Tracks Biotherapeutics
8/10/2026Boost Price Target$46.70$65.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
8/7/2026Set Price Target$1,177.47$1,376.00
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
8/7/2026Boost Price Target$24.58$34.00Buy
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$407.83$440.00Buy
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Boost Price Target$204.32$240.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
7/13/2026Boost Price Target$481.82$585.00Buy
Amgen Inc. stock logo
AMGN
Amgen
7/13/2026Boost Price Target$358.76$420.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
7/13/2026Boost Price Target$246.93$260.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/13/2026Boost Price Target$1,188.32$1,425.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
7/1/2026Boost Price Target$95.17$130.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/23/2026Downgrade$132.55$135.11Neutral
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
6/15/2026Initiated Coverage$15.34$45.00Buy
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
6/15/2026Initiated Coverage$16.10$45.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
5/27/2026Reiterated Rating$26.34$27.00Neutral
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/13/2026Boost Price Target$65.58$76.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/28/2026Boost Price Target$82.12$100.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/22/2026Upgrade$185.95$225.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
4/21/2026Lower Price Target$53.19$60.00Buy
Amgen Inc. stock logo
AMGN
Amgen
4/13/2026Boost Price Target$349.82$400.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4/13/2026Boost Price Target$120.19$145.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
4/13/2026Boost Price Target$27.32$27.00Neutral
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/6/2026Boost Price Target$55.82$75.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
3/27/2026Boost Price Target$41.92$80.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
3/18/2026Reiterated Rating$915.76Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
3/17/2026Lower Price Target$12.48$13.00Neutral
A new kind of civil war is coming after election day? (Ad)

Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio.tc pixel

Read Whitney Tilson's free analysis on what could happen next.
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/17/2026Boost Price Target$66.88$90.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
3/6/2026Reiterated Rating$60.69$70.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/3/2026Lower Price Target$4.48$7.00Neutral
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
2/24/2026Reiterated Rating$37.10Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/24/2026Downgrade$113.75$115.00Neutral
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
2/17/2026Initiated Coverage$29.12$45.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
2/5/2026Lower Price Target$217.41$230.00Neutral
AbbVie Inc. stock logo
ABBV
AbbVie
2/5/2026Upgrade$220.74Hold
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/2/2026Reiterated Rating$1,050.45Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/26/2026Boost Price Target$473.83$545.00Buy
Amgen Inc. stock logo
AMGN
Amgen
1/26/2026Boost Price Target$349.03$390.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/26/2026Boost Price Target$137.73$155.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/15/2026Reiterated Rating$122.83Buy
AbbVie Inc. stock logo
ABBV
AbbVie
1/13/2026Reiterated Rating$220.24Neutral
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Reiterated Rating$13.73$14.00Neutral
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Downgrade$13.81$14.00Hold
Arcellx, Inc. stock logo
ACLX
Arcellx
1/7/2026Initiated Coverage$62.98Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
1/7/2026Initiated Coverage$17.72Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1/7/2026Initiated Coverage$31.05$50.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/7/2026Initiated Coverage$10.05$20.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
1/7/2026Initiated Coverage$1.41$8.00Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
1/7/2026Initiated Coverage$18.20$35.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
1/7/2026Initiated Coverage$41.31$60.00Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
1/7/2026Initiated Coverage$18.79$18.00Neutral
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
1/7/2026Initiated Coverage$3.62$7.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
1/7/2026Initiated Coverage$26.62$50.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
1/7/2026Initiated Coverage$25.04$45.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/7/2026Initiated Coverage$8.47$10.00Neutral
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
1/7/2026Initiated Coverage$25.05$50.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
1/7/2026Initiated Coverage$28.70$60.00Buy
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
1/7/2026Initiated Coverage$4.54$12.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
1/7/2026Set Price Target$32.85$55.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
1/7/2026Initiated Coverage$17.21$25.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
1/7/2026Initiated Coverage$28.34$28.00Neutral
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
1/7/2026Initiated Coverage$43.91$70.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
1/7/2026Initiated Coverage$8.76$20.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
1/7/2026Initiated Coverage$62.06$100.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1/7/2026Upgrade$54.45$65.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/7/2026Initiated Coverage$121.36$145.00Buy
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
1/7/2026Initiated Coverage$37.28$50.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
1/7/2026Upgrade$33.76$55.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
1/7/2026Initiated Coverage$10.33$20.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
1/7/2026Initiated Coverage$1.49$8.00Buy
Amgen Inc. stock logo
AMGN
Amgen
1/7/2026Upgrade$330.11Strong-Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
1/7/2026Reiterated Rating$43.80$70.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
1/7/2026Initiated Coverage$28.00$28.00Hold
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
1/7/2026Reiterated Rating$4.92$12.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
1/7/2026Initiated Coverage$26.62$50.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
1/7/2026Initiated Coverage$30.72$60.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/7/2026Initiated Coverage$8.46$10.00Hold
How Elon’s Empire Ends (and how to profit) (Ad)

Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days.tc pixel

See Chaikin's full research and the company name here
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
1/7/2026Initiated Coverage$25.57$45.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
1/7/2026Initiated Coverage$26.40$50.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
1/7/2026Initiated Coverage$3.86$7.00Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
1/7/2026Initiated Coverage$18.61$18.00Hold
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
1/7/2026Initiated Coverage$41.67$60.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1/7/2026Initiated Coverage$30.33$50.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/7/2026Initiated Coverage$13.84$20.00Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
1/7/2026Initiated Coverage$18.50$35.00Buy
Biogen Inc. stock logo
BIIB
Biogen
1/6/2026Initiated Coverage$182.61$185.00Neutral
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/6/2026Initiated Coverage$468.58$535.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1/6/2026Initiated Coverage$1,063.95$1,250.00Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
3/6/2025Upgrade$1.04$3.00Buy